BIOMARKERS with Identifiers (Test:ID)

Breast Biomarkers

Biomarker	Assay Purpose	Drug(s)	Diagnostic Test	Test ID
PD-L1	Triple Negative Breast Cancer (TNBC)	Pembrolizumab	PDL1 Dako 22C3 PharmDX	PDL1TNBC22C3PEMBRO

Gastrointestinal Biomarkers

Biomarker	Assay Purpose	Drug(s)	Diagnostic Test	Test ID
PD-L1	Gastric, GEJ, esophageal adenocarcinoma; ESCC	Pembrolizumab, Nivolumab	PDL1 Dako 22C3 PharmDX	PDL1UPPERGIMARCH2026
Claudin 18.2	Gastric or GEJ adenocarcinoma	Zolbetuximab	VENTANA CLDN18 (43-14A) RxDx	BMCLAUDIN18

Gyne Biomarkers

Biomarker	Assay Purpose	Drug(s)	Diagnostic Test	Test ID
PD-L1	Cervical cancer (SCC and Adenocarcinoma)	Pembrolizumab	PDL1 Dako 22C3 PharmDX	PDL1CERVIX
CEP17 SISH	Ploidy Analysis	N/A	VENTANA Inform Chromosome 17 probe	MOLARCEP17

Head & Neck Biomarkers

Biomarker	Assay Purpose	Drug(s)	Diagnostic Test	Test ID
PD-L1	Advanced HNSCC	Pembrolizumab	PDL1 Dako 22C3 PharmDX	PDL1HNSCC22C3PEMBRO
PD-L1	Resectable HNSCC	Pembrolizumab as Neoadjuvant	PDL1 Dako 22C3 PharmDX	PDL1HNSCCNEOADPEMBRO

Lung Biomarkers

Biomarker	Assay Purpose	Drug(s)	Diagnostic Test	Test ID
PD-L1	NSCLC stage IIIb to IV	Pembrolizumab	PDL1 22C3	PDL1NSCLCPEMBRO22C3
PD-L1	NSCLC stage II to IIIA	Atezolizumab as Adjuvant	PDL1 SP263	PDL1NSCLCATEZOSP263
ALK	NSCLC	alectinib, lorlatinib	ALK OTI1A4	LUALKNEW

Agnostic Biomarkers and miscellaneous

Biomarker	Assay Purpose	Drug(s)	Diagnostic Test	Test ID
pan-TRK	Any primary	TRK inhibitors (Larotrectinib)	pan-TRK	PANTRK
PD-L1 IHC NON-REPORTABLE	Any primary	NA	Any clone	MDHPDL1NONREPORTABLE

Summary List